Literature DB >> 794454

Immunological and non-immunological phagocytosis by inflammatory macrophages, epithelioid cells and macrophage polykaryons from foreign body granulomata.

M Mariano, T Nikitin, B E Malucelli.   

Abstract

Inflammatory macrophages, epithelioid cells and macrophage polykaryons were obtained on the surface of round glass coverslips inserted into the subcutaneous tissue of mice and removed at different intervals. About 90 per cent of the macrophages and polykaryons express IgG, C and non-specific surface receptors, involved in phagocytosis, up to 15 days after coverslip implantation. In 21-day-old lesions, about 50 per cent of these cells lose the IgG resed with IgM and complement but do not incorporate these particles and are poorly phagocytic for glutaraldehyde-treated horse red blood cells. The ultrastructural study of these cells demonstrates that they are macrophages which have undergone epithelioid transformation. Whole-body irradiation of mice bearing implanted coverslips of 7 days duration reveals that 6 days after irradiation, the great majority of macrophages and multinucleate cells have acquired epithelioid characteristics. It is suggested that the loss of immunological receptors during epithelioid transformation in granulomas may protect bacteria and be disadvantageous to the host.

Entities:  

Mesh:

Year:  1976        PMID: 794454     DOI: 10.1002/path.1711200304

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  12 in total

1.  Lipids from Mycobacterium leprae cell wall are endowed with an anti-inflammatory property and inhibit macrophage function in vivo.

Authors:  A C Moura; M Mariano
Journal:  Immunology       Date:  1996-12       Impact factor: 7.397

2.  Electrophysiology of phagocytic membranes: induction of slow membrane hyperpolarizations in macrophages and macrophage polykaryons by intracellular calcium injection.

Authors:  P M Persechini; E G Araujo; G M Oliveira-Castro
Journal:  J Membr Biol       Date:  1981       Impact factor: 1.843

3.  Characterization of the binucleated giant cells generated in the autologous mixed leucocyte reaction from patients with rheumatoid arthritis.

Authors:  M Goto; V Tsai; N J Zvaifler
Journal:  Clin Exp Immunol       Date:  1990-08       Impact factor: 4.330

4.  Lack of Fc receptors on osteoclasts.

Authors:  N Hogg; I M Shapiro; S J Jones; M Slusarenko; A Boyde
Journal:  Cell Tissue Res       Date:  1980       Impact factor: 5.249

5.  Tissue localization of complement component 3 receptor-bearing cells in lymphoid tissue after injection with complete Freund adjuvant.

Authors:  H Okuyama; S Kobayashi; M Fujita; R Yasumizu; K Morikawa
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

6.  Fc-receptor-bearing macrophages isolated from hypersensitivity and foreign-body granulomas. Delineation of macrophage dynamics, fc receptor density/avidity and specificity.

Authors:  A F Amsden; D L Boros
Journal:  Am J Pathol       Date:  1979-08       Impact factor: 4.307

Review 7.  Granulomatous inflammation--a review.

Authors:  G T Williams; W J Williams
Journal:  J Clin Pathol       Date:  1983-07       Impact factor: 3.411

8.  Giant cell stromal reaction in squamous cell carcinomata. Electronmicroscopic and ultrahistochemical observations on the genesis and functional activity of multinucleated giant cells in bleomycin-induced tumor regression.

Authors:  A Burkhardt; J O Gebbers
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1977-10-07

9.  Murine macrophages cultured with IL-4 acquire a phenotype similar to that of epithelioid cells from granulomatous inflammation.

Authors:  Ivone Martins Cipriano; Mario Mariano; Edna Freymüller; Celia Regina Whitaker Carneiro
Journal:  Inflammation       Date:  2003-08       Impact factor: 4.092

10.  Functional and biochemical studies of multinucleated giant cells derived from the culture of human monocytes.

Authors:  L Schlesinger; R A Musson; R B Johnston
Journal:  J Exp Med       Date:  1984-04-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.